Journal Articles

• Devlin AJ, Mycroft-West CJ, Turnbull JE, de Lima MA, Guerrini M, Yates EA, Skidmore MA. 2023. Analysis of Heparin Samples by Attenuated Total Reflectance Fourier-Transform Infrared Spectroscopy in the Solid State. ACS CENTRAL SCIENCE. link> doi> full text>
• Maciej-Hulme ML, Leprince ACN, Lavin A, Guimond SE, Turnbull JE, Pelletier J, Yates EA, Powell AK, Skidmore MA. 2023. High sensitivity (zeptomole) detection of BODIPY-labelled heparan sulfate (HS) disaccharides by ion-paired RP-HPLC and LIF detection enables analysis of HS from mosquito midguts. Anal Methods, 1461-1469, vol. 15(11). link> doi> full text>
• Mycroft-West CJ, Devlin AJ, Cooper LC, Guimond SE, Procter P, Miller GJ, Guerrini M, Fernig DG, Yates EA, Lima MA, Skidmore MA. 2023. A sulphated glycosaminoglycan extract from Placopecten magellanicus inhibits the Alzheimer's disease β-site amyloid precursor protein cleaving enzyme 1 (BACE-1). Carbohydr Res, 108747, vol. 525. link> doi> full text>
• Parafioriti M, Ni M, Petitou M, Mycroft-West CJ, Rudd TR, Gandhi NS, Ferro V, Turnbull JE, Lima MA, Skidmore MA, Fernig DG, Yates EA, Bisio A, Guerrini M, Elli S. 2023. Evidence for Multiple Binding Modes in the Initial Contact Between SARS-CoV-2 Spike S1 Protein and Cell Surface Glycans. Chemistry, e202202599, vol. 29(1). link> doi> full text>
• Su D, Li Y, Yates EA, Skidmore MA, Lima MA, Fernig DG. 2022. Analysis of protein-heparin interactions using a portable SPR instrument. PeerJ Analytical Chemistry, 1-16, vol. 4. doi> link> full text>
• Guimond SE, Mycroft-West CJ, Gandhi NS, Tree JA, Le TT, Spalluto CM, Humbert MV, Buttigieg KR, Coombes N, Elmore MJ, Wand M, Nyström K, Said J, Setoh YX, Amarilla AA, Modhiran N, Sng JDJ, Chhabra M, Young PR, Rawle DJ, Lima MA, Yates EA, Karlsson R, Miller RL, Chen Y-H, Bagdonaite I, Yang Z, Stewart J, Nguyen D, Laidlaw S, Hammond E, Dredge K, Wilkinson TMA, Watterson D, Khromykh AA, Suhrbier A, Carroll MW, Trybala E, Bergström T, Ferro V, Skidmore MA, Turnbull JE. 2022. Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction. ACS Cent Sci, 527-545, vol. 8(5). link> doi> full text>
• Davies SP, Mycroft-West CJ, Pagani I, Hill HJ, Chen Y-H, Karlsson R, Bagdonaite I, Guimond SE, Stamataki Z, De Lima MA, Turnbull JE, Yang Z, Vicenzi E, Skidmore MA, Khanim FL, Richardson A. 2021. The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models. Front Pharmacol, 660490, vol. 12. link> doi> full text>
• Mycroft-West CJ, Devlin AJ, Cooper LC, Guimond SE, Procter P, Guerrini M, Miller GJ, Fernig DG, Yates EA, Lima MA, Skidmore MA. 2021. Glycosaminoglycans from Litopenaeus vannamei Inhibit the Alzheimer's Disease β Secretase, BACE1. Mar Drugs, vol. 19(4). link> doi> full text>
• Schuurs ZP, Hammond E, Elli S, Rudd TR, Mycroft-West CJ, Lima MA, Skidmore MA, Karlsson R, Chen Y-H, Bagdonaite I, Yang Z, Ahmed YA, Richard DJ, Turnbull J, Ferro V, Coombe DR, Gandhi NS. 2021. Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain. Comput Struct Biotechnol J, 2806-2818, vol. 19. link> doi> full text>
• Mycroft-West CJ, Su D, Pagani I, Rudd TR, Elli S, Gandhi NS, Guimond SE, Miller GJ, Meneghetti MCZ, Nader HB, Li Y, Nunes QM, Procter P, Mancini N, Clementi M, Bisio A, Forsyth NR, Ferro V, Turnbull JE, Guerrini M, Fernig DG, Vicenzi E, Yates EA, Lima MA, Skidmore MA. 2020. Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin. Thromb Haemost, 1700-1715, vol. 120(12). link> doi> full text>
• Lima MA, Skidmore M, Khanim F, Richardson A. 2021. Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2. Biochem Biophys Res Commun, 485-490, vol. 534. link> doi> full text>
• Hyatt JG, Prévost S, Devos JM, Mycroft-West CJ, Skidmore MA, Winter A. 2020. Molecular Changes in Dengue Envelope Protein Domain III upon Interaction with Glycosaminoglycans. Pathogens, vol. 9(11). link> doi> full text>
• Tree JA, Turnbull JE, Buttigieg KR, Elmore MJ, Coombes N, Hogwood J, Mycroft-West CJ, Lima MA, Skidmore MA, Karlsson R, Chen Y-H, Yang Z, Spalluto CM, Staples KJ, Yates EA, Gray E, Singh D, Wilkinson T, Page CP, Carroll MW. 2021. Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations. Br J Pharmacol, 626-635, vol. 178(3). link> doi> full text>
• Mycroft-West C, Su D, Li Y, Guimond S, Rudd T, Elli S, Miller G, Nunes Q, Procter P, Bisio A, Forsyth N, Turnbull J, Guerrini M, Fernig D, Yates E, Lima M, Skidmore M. 2020. Glycosaminoglycans induce conformational change in the SARS-CoV-2 Spike S1 Receptor Binding Domain. doi>
• Mycroft-West C, Su D, Li Y, Guimond S, Rudd T, Elli S, Miller G, Nunes Q, Procter P, Bisio A, Forsyth N, Turnbull J, Guerrini M, Fernig D, Yates E, Lima M, Skidmore M. 2020. SARS-CoV-2 Spike S1 Receptor Binding Domain undergoes Conformational Change upon Interaction with Low Molecular Weight Heparins. doi>
• Mycroft-West C, Su D, Pagani I, Rudd T, Elli S, Guimond S, Miller G, Meneghetti M, Nader H, Li Y, Nunes Q, Procter P, Mancini N, Clementi M, Bisio A, Forsyth N, Turnbull J, Guerrini M, Fernig D, Vicenzi E, Yates E, Lima M, Skidmore M. 2020. Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the surface protein (spike) S1 receptor binding domain with heparin. doi>
• Mycroft-West C, Su D, Elli S, Li Y, Li Y, Guimond S, Miller G, Turnbull J, Yates E, Guerrini M, Fernig D, Lima M, Skidmore M. 2020. The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 Receptor Binding Domain undergoes conformational change upon heparin binding. doi>
• Mycroft-West CJ, Devlin AJ, Cooper LC, Procter P, Miller GJ, Fernig DG, Guerrini M, Guimond SE, Lima MA, Yates EA, Skidmore MA. 2020. Inhibition of BACE1, the β-secretase implicated in Alzheimer's disease, by a chondroitin sulfate extract from Sardina pilchardus. Neural Regen Res, 1546-1553, vol. 15(8). link> doi> full text>
• Devlin A, Mycroft-West C, Procter P, Cooper L, Guimond S, Lima M, Yates E, Skidmore M. 2019. Tools for the Quality Control of Pharmaceutical Heparin. Medicina, 636, vol. 55(10). doi> link> full text>
• Mycroft-West CJ, Cooper LC, Devlin AJ, Procter P, Guimond SE, Guerrini M, Fernig DG, Lima MA, Yates EA, Skidmore MA. 2019. A Glycosaminoglycan Extract from Portunus pelagicus Inhibits BACE1, the β Secretase Implicated in Alzheimer's Disease. Mar Drugs, vol. 17(5). link> doi> full text>
• Mycroft-West CJ, Yates EA, Skidmore MA. 2018. Marine glycosaminoglycan-like carbohydrates as potential drug candidates for infectious disease. Biochem Soc Trans, 919-929, vol. 46(4). link> doi>
• Maciej-Hulme ML, Skidmore MA, Price HP. 2018. The role of heparan sulfate in host macrophage infection by Leishmania species. Biochem Soc Trans, 789-796, vol. 46(4). link> doi> full text>
• Joseph H, Skidmore MA, Edwin Y. 2018. An Inexpensive, Pulsed, and Multiple Wavelength Bench-Top Light Source for Biological Spectroscopy. Plasma, vol. 1(1). doi> link> full text>
• Vicenzi E, Pagani I, Ghezzi S, Taylor SL, Rudd TR, Lima MA, Skidmore MA, Yates EA. 2018. Subverting the mechanisms of cell death: flavivirus manipulation of host cell responses to infection. Biochem Soc Trans, 609-617, vol. 46(3). link> doi> full text>
• Rogerson E, Pelletier J, Acosta-Serrano A, Rose C, Taylor S, Guimond S, Lima M, Skidmore M, Yates E. 2018. Variations in the Peritrophic Matrix Composition of Heparan Sulphate from the Tsetse Fly, Glossina morsitans morsitans. Pathogens, vol. 7(1). link> doi> full text>
• Kareem N, Yates E, Skidmore M, Hoole D. 2017. In vitro investigations on the effects of semi-synthetic, sulphated carbohydrates on the immune status of cultured common carp (Cyprinus carpio) leucocytes. Fish and Shellfish Immunology. link> doi> link> full text>
• Boyle MJ, Skidmore M, Dickerman B, Cooper L, Devlin A, Yates E, Horrocks P, Freeman C, Chai W, Beeson JG. 2017. Identification of Heparin Modifications and Polysaccharide Inhibitors of Plasmodium falciparum Merozoite Invasion That Have Potential for Novel Drug Development. Antimicrob Agents Chemother, vol. 61(11). link> doi> full text>
• Skidmore MA, Mustaffa KMF, Cooper LC, Guimond SE, Yates EA, Craig AG. 2017. A semi-synthetic glycosaminoglycan analogue inhibits and reverses Plasmodium falciparum cytoadherence. PLoS One, e0186276, vol. 12(10). link> doi> full text>
• Ghezzi S, Cooper L, Rubio A, Pagani I, Capobianchi MR, Ippolito G, Pelletier J, Meneghetti MCZ, Lima MA, Skidmore MA, Broccoli V, Yates EA, Vicenzi E. 2017. Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells. Antiviral Res, 13-17, vol. 140. link> doi> full text>
• Lima MA, Cavalheiro RP, M Viana G, Meneghetti MCZ, Rudd TR, Skidmore MA, Powell AK, Yates EA. 2017. 19F labelled glycosaminoglycan probes for solution NMR and non-linear (CARS) microscopy. Glycoconj J, 405-410, vol. 34(3). link> doi> full text>
• Curtis ADM, Malekigorji M, Holman J, Skidmore M, Hoskins C. 2015. Heat Dissipation of Hybrid Iron Oxide-Gold Nanoparticles in an Agar Phantom. Journal of Nanomedicine and Nanotechnology. doi> full text>
• Skidmore MA, Kajaste-Rudnitski A, Wells NM, Guimond SE, Rudd TR, Yates EA, Vicenzi E. 2015. Inhibition of influenza H5N1 invasion by modified heparin derivatives. MEDCHEMCOMM, 640-646, vol. 6(4). link> doi>
• Veraldi N, Hughes AJ, Rudd TR, Thomas HB, Edwards SW, Hadfield L, Skidmore MA, Siligardi G, Cosentino C, Shute JK, Naggi A, Yates EA. 2015. Heparin derivatives for the targeting of multiple activities in the inflammatory response. Carbohydrate Polymers, 400-407, vol. 117. link> doi> link>
• Xu R, Ori A, Rudd TR, Uniewicz KA, Ahmed YA, Guimond SE, Skidmore MA, Siligardi G, Yates EA, Fernig DG. 2012. Diversification of the Structural Determinants of Fibroblast Growth Factor-Heparin Interactions IMPLICATIONS FOR BINDING SPECIFICITY. JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 287(47). link> doi>
• Rudd TR, Gaudesi D, Skidmore MA, Ferro M, Guerrini M, Mulloy B, Torri G, Yates EA. 2011. Construction and use of a library of bona fide heparins employing H-1 NMR and multivariate analysis. ANALYST, 1380-1389, vol. 136(7). link> doi>
• Rudd TR, Gaudesi D, Lima MA, Skidmore MA, Mulloy B, Torri G, Nader HB, Guerrini M, Yates EA. 2011. High-sensitivity visualisation of contaminants in heparin samples by spectral filtering of H-1 NMR spectra. ANALYST, 1390-1398, vol. 136(7). link> doi>
• SKIDMORE MA, GUIMOND SE, DUMAX-VORZET AF, YATES EA, TURNBULL JE. 2010. Disaccharide compositional analysis of heparan sulfate and heparin polysaccharides using UV or high-sensitivity fluorescence (BODIPY) detection. NATURE PROTOCOLS. doi>
• Rudd TR, Skidmore MA, Guerrini M, Hricovini M, Powell AK, Siligardi G, Yates EA. 2010. The conformation and structure of GAGs: recent progress and perspectives. Current Opinions in structural biology, 567-574. doi>
• RUDD T, UNIEWICZ K, ORI A, GUIMOND S, SKIDMORE M, GAUDESI D, XU R, TURNBULL J, GUERRINI M, TORRI G, SILIGARDI G, FERNIG D, WILKINSON M, YATES E. 2010. Comparable stabilization, structural changes and activites can be induced in FGF by a variety of HS and non-GAG analogues: Implications for sequence-activity relationships. ORGANIC AND BIOMOLECULAR CHEMISTRY. doi>
• HOLMAN J, SKIDMORE M, RUDD T, YATES E. 2010. The latent ampholytic nature of glycosaminoglycan (GAG) oligosaccharides facilitates their separation by isoelectric focusing. ANALYTICAL METHODS, 1550-1554, vol. 2(10).
• RUDD T, SKIDMORE M, GUIMOND S, HOLMAN J, TURNBULL J, LAUDER R, FERNIG D, YATES E. 2009. The potential for circular dichroism as an additional facile and sensitive method of monitoring low-molecular-weight heparins and heparinoids. THROMBOSIS AND HAEMOSTASIS, 874-878, vol. 102(5). doi>
• GUIMOND S, PUVIRAJESINGHE T, SKIDMORE M, KALUS I, DIERKS T, YATES E, TURNBULL J. 2009. Rapid purification and high sensitivity analysis of heparan sulfate from cells and tissues: toward glycomics profiling. JOURNAL OF BIOLOGICAL CHEMISTRY, 25714-25722, vol. 284. doi>
• Skidmore MA, Guimond SE, Rudd TR, Fernig DG, Turnbull JE, Yates EA. 2008. The activities of heparan sulfate and its analogue heparin are dictated by biosynthesis, sequence, and conformation. Connect Tissue Res, 140-144, vol. 49(3). link> doi>
• GUIMOND S, SKIDMORE M, ORI A, GAUDESI D, COSENTINO C, GUERRINI M, EDGE R, COLLISON D, MCINNES E, TORRI G, TURNBULL J, FERNIG D, YATES E. 2009. Cations modulate polysaccharide structure to determine FGF-FGFR signaling: a comparison of signaling and inhibitory polysaccharide interactions with FGF-1 in solution. BIOCHEMISTRY, 4772-4779, vol. 48. doi>
• RUDD T, SKIDMORE M, GUIMOND S, COSENTINO C, TORRI G, FERNIG D, LAUDER R, GUERRINI M, YATES E. 2009. Glycosaminoglycan origin and structure revealed by multivariate analysis of NMR and CD spectra. GLYCOBIOLOGY, 52-67, vol. 19. doi>
• SKIDMORE M, ATRIH A, YATES E, TURNBULL E. 2009. Labelling heparan sulphate saccharides with chromophore, fluorescence and mass tags for HPLC and MS separations. METHODS IN MOLECULAR BIOLOGY, 157-169, vol. 534.
• RUDD T, SKIDMORE M, GUIMOND S, GUERRINI M, COSENTINO C, EDGE R, BROWN A, CLARKE D, TORRI G, TURNBULL J, NICHOLS R, FERNIG D, YATES E. 2008. Site-specific interactions of copper(II) ions with heparin revealed with complementary (SRCD, NMR, FTIR and EPR) spectroscopic techniques. CARBOHYDRATE RESEARCH, 2184-2193, vol. 343. doi>
• SKIDMORE M, DUMAX-VORZET A, GUIMOND S, RUDD T, EDWARDS E, TURNBULL J, CRAIG A, YATES E. 2008. Disruption of rosetting in Plasmodium falciparum malaria with chemically modified heparin and low molecular weight derivatives, possessing reduced anticoagulant and other serine protease inhibition activities. JOURNAL OF MEDICINAL CHEMISTRY, 1453-1458, vol. 51. doi>
• SKIDMORE M, GUIMOND S, RUDD T, FERNIG D, TURNBULL J, YATES E. 2008. The activities of the cell surface expressed glycosaminoglycan heparan sulfate and its analogue heparin are dictated by biosynthesis, sequence and conformation. CONNECTIVE TISSUE RESEARCH, 140-144, vol. 49.
• RUDD T, GUIMOND S, SKIDMORE M, DUSCHESNE L, GUERRINI M, TORRI G, COSENTINO C, BROWN A, CLARKE D, TURNBULL J, FERNIG D, YATES E. 2007. Influence of substitution pattern and cation binding on conformation and activity in heparin derivatives. GLYCOBIOLOGY, 983-993, vol. 17(9). doi>
• SKIDMORE M, GUIMOND S, DUMAX-VORZET A, ATRIH A, YATES E, TURNBULL J. 2006. High sensitivity separation and detection of heparin / heparan sulfate disaccharides. JOURNAL OF CHROMATOGRAPHY A, 52, vol. 1135(1). doi>
• SKIDMORE M, PATEY S, THANH N, FERNIG D, TURNBULL J, YATES E. 2004. Attachment of glycosaminoglycan oligosaccharides to thiol-derivatised gold surfaces. CHEMICAL COMMUNICATIONS, 2700, vol. 7(23). doi>
• Kareem N, Skidmore M, Hoole D. 2017. In vitro investigations on the effects of different polysaccharides structure and form on common carp (Cyprinus carpio) immune properties. PH.D. project publication.

Chapters

• YATES E, RUDD T, DUSCHESNE L, SKIDMORE M, NICHOLS R, CLARKE D, FERNIG D. 2007. Revealing the hidden dimensions of GAGs in solution and protein complexes with saccharide libraries, FTIR and SRCD. In GLYCOBIOLOGY. SAMSON C and MARKHAM O (Eds.). BLOXHAM, UK: SCION.
• SKIDMORE M and TURNBULL J. 2005. Sequencing and separation of heparan sulfate. In Chemistry and Biology of Heparin and Heparan sulfate. GARG H, LINHARDT R, HALES C (Eds.). NEW YORK, USA: ELSEVIER B.V..
• RUDD T, SKIDMORE M, YATES E. 2005. Surface-Based Studies of Heparin/Heparan Sulfate-Protein Interactions. In Chemistry and Biology of Heparin and Heparan sulfate. GARG H, LINHARDT R, HALES C (Eds.). NEW YORK, USA: ELSEVIER B.V..

Other

• SKIDMORE M, SWEENIE C, MUSTAFFA K, WILSON H, GUIMOND S, TURNBULL A, ROWE J, YATES E. 12th International Congress of Parasitology (ICOPA).